The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer - A systematic review and meta-analysis

Please use this identifier to cite or link to this item: https://doi.org/10.1002/jso.21911

Title:	The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer - A systematic review and meta-analysis
Authors:	Tan, V.K.M. Goh, B.K.P. Fook-Chong, S. Khin, L.-W. Wong, W.-K. Yong, W.-S.
Keywords:	Breast cancer Neoadjuvant chemotherapy Sentinel lymph node biopsy
Issue Date:	1-Jul-2011
Citation:	Tan, V.K.M., Goh, B.K.P., Fook-Chong, S., Khin, L.-W., Wong, W.-K., Yong, W.-S. (2011-07-01). The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer - A systematic review and meta-analysis. Journal of Surgical Oncology 104 (1) : 97-103. ScholarBank@NUS Repository. https://doi.org/10.1002/jso.21911
Abstract:	The sentinel lymph node biopsy (SLNB) is now an accepted alternative to the axillary lymph node dissection for pathologic evaluation of the axilla in patients with early breast cancer. The use of SLNB after neoadjuvant chemotherapy (NAC) is controversial. This meta-analysis aims to determine the feasibility and the accuracy of SLNB in the population of patients who are clinically node-negative after NAC for breast cancer. © 2011 Wiley-Liss, Inc.
Source Title:	Journal of Surgical Oncology
URI:	http://scholarbank.nus.edu.sg/handle/10635/126594
ISSN:	00224790
DOI:	10.1002/jso.21911
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check